PMC2546471_01
Pyoderma gangrenosum at baseline before amelogenin application.
cia0302-263-03a.jpg
PMC2546471_01_cia0302-263-03a.jpg
fig3a
The lesions improved, showing advances in granulation tissue formation and wound size reduction (Figures 3a-c).